11 patents
Utility
Stable protein formulations comprising a molar excess of sorbitol
13 Jul 21
A stable pharmaceutical formulation comprising a protein of interest, sorbitol and polyethylene glycol (PEG).
Kala Chandramouli, Rohan Pai
Filed: 16 Apr 15
Utility
Process for the Preparation of Abametapir and Its Pharmaceutically Acceptable Salts
6 Jan 21
The present invention relates to process for the preparation of Abametapir.
Sureshbabu JAYACHANDRA, Madhuresh Sethi, Vipin Kumar KAUSHIK, Vijaya Krishna Ravi, Saiprasad Kottalla
Filed: 7 Mar 19
Utility
Polymorphic forms of VENCLEXTA
12 Oct 20
The present disclosure relates to crystalline forms of venetoclax and process for their preparation.
Ramakoteswara Rao Jetti, Hemant Malhari Mande, Anjaneyaraju Indukuri, Narasimha Murthy Pilli, Rajesh Joshi, Anil Kumar Tripathi, Chandrakant Chaudhri, Kiran Pokharkar, Nagaraju Gottumukkala
Filed: 12 Oct 17
Utility
Processes for the Preparation of Amorphous Tenofovir Alafenamide Hemifumarate and a Premix Thereof
19 Aug 20
An amorphous form of tenofovir alafenamide hemifumarate and process for the preparation of the same.
Ramakoteswara Rao Jetti, Amit Singh, Neelima Bhagavatula, Anjaneyaraju Indukuri, B. A. Ramireddy
Filed: 17 Dec 19
Utility
Polymorphic forms of sofosbuvir
10 Aug 20
The present disclosure provides novel crystalline sofosbuvir form-M3 and a process for the preparation of sofosbuvir form-M3.
Ramakoteswara Rao Jetti, Hemant Malhari Mande, Anjaneyaraju Indukuri, Narasimha Murty Pilli, Ravi Venkata Naga Vikas Chandra Dev, Vijaya Krishna Ravi
Filed: 16 Mar 17
Utility
Process for the preparation of dolutegravir
3 Aug 20
Processes for the preparation of dolutegravir and pharmaceutically acceptable salts utilizing alkenylamine are disclosed.
Sivaram Prasad Vellanki, Madumurthy Nadella, Mitali Bhalme, Revathi Srinivas Ramabhotla, Venkata Siva Reddy Arumalla, Raveendra Babu Kilaru
Filed: 4 Feb 16
Utility
Composition for treatment of warts
20 Jul 20
The present invention concerns a pharmaceutical composition comprising formic acid and at least one C1-C4 alkyl ester of lactic acid, malic acid, tartaric acid, citric acid, preferably ethyl lactate, for the topical treatment of warts.
Flemming Licht
Filed: 27 May 12
Utility
Polymorph of an intermediate for palbociclib synthesis
13 Jul 20
The present disclosure provides a novel polymorph of an intermediate useful in the preparation of palbociclib.
Mahdeshkumar Gadakar, Dnyandeo Punde, Rajendra Yadav, Yogesh Wakchaure
Filed: 3 Oct 17
Utility
Aerosolization Apparatus with Capsule Puncture Alignment Guide
24 Jun 20
An aerosolization apparatus comprises a housing defining a chamber having one or more air inlets.
Michael John Dunkley, Jon David Tuckwell, Edward William Vernon-Harcourt, Mark Glusker, Steve Paboojian
Filed: 27 Jan 19
Utility
Process to Convert Technical Ascomycin into Purified Pimecrolimus
11 Mar 20
The present disclosure is directed to an improved process to convert crude ascomycin to purified pimecrolimus.
Borut Gabriel, Aljaz Kajtna, Ajna Lukic, Dominic De Souza, Werner Hasselwander
Filed: 1 May 18
Utility
Oral composition
2 Mar 20
The present invention relates to a composition comprising an antibacterial agent in an amount insufficient to provide antibacterial effect, a physiologically acceptable divalent metal ion in a very low concentration and a physiologically acceptable polymer for preventing and/or treating halitosis, bad breath, dry mouth or sore throat.
Thomas Berglund
Filed: 16 Jun 15
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first